Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network).

Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999.

PMID:
30675755
2.

A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.

Harari S, Caminati A, Poletti V, Confalonieri M, Gasparini S, Lacedonia D, Luppi F, Pesci A, Sebastiani A, Spagnolo P, Vancheri C, Balestro E, Bonifazi M, Cerri S, De Giacomi F, Della Porta R, Foschino Barbaro MP, Fui A, Pasquinelli P, Rosso R, Tomassetti S, Specchia C, Rottoli P; for the ILDINET (Interstitial Lung Diseases Italian Network).

Respiration. 2018;95(6):433-440. doi: 10.1159/000487711. Epub 2018 Mar 27.

3.

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.

Ferrara G, Luppi F, Birring SS, Cerri S, Caminati A, Sköld M, Kreuter M.

Eur Respir Rev. 2018 Feb 7;27(147). pii: 170076. doi: 10.1183/16000617.0076-2017. Print 2018 Mar 31. Review.

4.

The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy.

Conti S, Harari S, Caminati A, Zanobetti A, Schwartz JD, Bertazzi PA, Cesana G, Madotto F.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700397. doi: 10.1183/13993003.00397-2017. Print 2018 Jan.

5.

Severe idiopathic pulmonary fibrosis: A clinical approach.

Lipsi R, Mazzola D, Caminati A, Elia D, Lonati C, Harari S.

Eur J Intern Med. 2018 Apr;50:20-27. doi: 10.1016/j.ejim.2018.01.014. Epub 2018 Feb 1. Review.

PMID:
29361476
6.

Recent advances in managing idiopathic pulmonary fibrosis.

Scelfo C, Caminati A, Harari S.

F1000Res. 2017 Nov 27;6:2052. doi: 10.12688/f1000research.10720.1. eCollection 2017. Review.

7.

[OssERvare Project: direct observation of use of the Safety Surgery CheckList in the operating room.]

Bentivegna R, Caminati A, Agnoletti V, Bonilauri S, Buonaccorso S, Campaniello G, Dovani A, Lanciotti G, Maselli V, Mastrangelo S, Montella MT, Palladino T, Pelati C, Sciolino L, Zoni E, Porcu E, Campagna A, Nicastro O.

Recenti Prog Med. 2017 Nov;108(11):476-480. doi: 10.1701/2812.28442. Italian.

PMID:
29149164
8.

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.

Torre O, Elia D, Caminati A, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170042. doi: 10.1183/16000617.0042-2017. Print 2017 Sep 30. Review.

9.

Severe idiopathic pulmonary fibrosis: what can be done?

Caminati A, Cassandro R, Torre O, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170047. doi: 10.1183/16000617.0047-2017. Print 2017 Sep 30. Review.

10.

Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada.

Harari S, Caminati A, Madotto F, Conti S, Cesana G.

Eur Respir J. 2017 Jan 25;49(1). pii: 1601504. doi: 10.1183/13993003.01504-2016. Print 2017 Jan. No abstract available.

11.

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.

Harari S, Madotto F, Caminati A, Conti S, Cesana G.

PLoS One. 2016 Feb 3;11(2):e0147072. doi: 10.1371/journal.pone.0147072. eCollection 2016.

12.

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation.

Caminati A, Madotto F, Cesana G, Conti S, Harari S.

Eur Respir Rev. 2015 Sep;24(137):436-44. doi: 10.1183/16000617.0040-2015. Review.

13.

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences.

Harari S, Caminati A.

Eur Respir Rev. 2015 Sep;24(137):420-7. doi: 10.1183/16000617.0042-2015. Review.

14.

Smoking-related idiopathic interstitial pneumonia: A review.

Margaritopoulos GA, Harari S, Caminati A, Antoniou KM.

Respirology. 2016 Jan;21(1):57-64. doi: 10.1111/resp.12576. Epub 2015 Jul 2. Review.

15.

Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.

Harari S, Caminati A, Albera C, Vancheri C, Poletti V, Pesci A, Luppi F, Saltini C, Agostini C, Bargagli E, Sebastiani A, Sanduzzi A, Giunta V, Della Porta R, Bandelli GP, Puglisi S, Tomassetti S, Biffi A, Cerri S, Mari A, Cinetto F, Tirelli F, Farinelli G, Bocchino M, Specchia C, Confalonieri M.

Respir Med. 2015 Jul;109(7):904-13. doi: 10.1016/j.rmed.2015.04.010. Epub 2015 Apr 25.

16.

Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.

Elia D, Torre O, Cassandro R, Caminati A, Harari S.

Eur J Intern Med. 2015 Jun;26(5):351-6. doi: 10.1016/j.ejim.2015.04.001. Epub 2015 Apr 17. Review.

PMID:
25899682
17.

Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.

Harari S, Caminati A, Cassandro R, Conti S, Madotto F, Luisi F, Cesana G.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):297-305.

PMID:
25591141
18.

Pulmonary hypertension in chronic interstitial lung diseases.

Caminati A, Cassandro R, Harari S.

Eur Respir Rev. 2013 Sep 1;22(129):292-301. doi: 10.1183/09059180.00002713. Review.

19.

Chickenpox-related pulmonary granulomas in immunocompetent adults: clinicopathologic and molecular features of an underrated occurrence.

Rossi G, Cavazza A, Gennari W, Marchioni A, Graziano P, Caminati A, Mengoli MC, Magnani R, Colby TV.

Am J Surg Pathol. 2012 Oct;36(10):1497-502. doi: 10.1097/PAS.0b013e31825fa4d8.

PMID:
22982893
20.

An integrated approach in the diagnosis of smoking-related interstitial lung diseases.

Caminati A, Cavazza A, Sverzellati N, Harari S.

Eur Respir Rev. 2012 Sep 1;21(125):207-17. doi: 10.1183/09059180.00003112.

21.

Smoking-related interstitial lung diseases.

Caminati A, Graziano P, Sverzellati N, Harari S.

Pathologica. 2010 Dec;102(6):525-36.

PMID:
21428116
22.

A 69-year-old female with multiple, bilateral pulmonary nodules.

Caminati A, Cavazza A, Mirenda MR, Harari S.

Eur Respir Rev. 2011 Mar;20(119):56-9. doi: 10.1183/09059180.00005010. No abstract available.

23.

Update on diffuse parenchymal lung disease.

Harari S, Caminati A.

Eur Respir Rev. 2010 Jun;19(116):97-108. doi: 10.1183/09059180.00002510. Review. No abstract available.

24.

IPF: New insight in diagnosis and prognosis.

Caminati A, Harari S.

Respir Med. 2010 Jul;104 Suppl 1:S2-10. doi: 10.1016/j.rmed.2010.03.012. Epub 2010 Jun 8.

25.

IPF: new insight on pathogenesis and treatment.

Harari S, Caminati A.

Allergy. 2010 May;65(5):537-53. doi: 10.1111/j.1398-9995.2009.02305.x. Epub 2010 Feb 1. Review.

PMID:
20121758
26.

The histology of pulmonary sarcoidosis: a review with particular emphasis on unusual and underrecognized features.

Cavazza A, Harari S, Caminati A, Barbareschi M, Carbonelli C, Spaggiari L, Paci M, Rossi G.

Int J Surg Pathol. 2009 Jun;17(3):219-30. doi: 10.1177/1066896909333748. Review.

PMID:
19443886
27.

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.

Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S.

Respir Med. 2009 Jan;103(1):117-23. doi: 10.1016/j.rmed.2008.07.022. Epub 2008 Sep 10.

28.

Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis.

Caminati A, Harari S.

Proc Am Thorac Soc. 2006 Jun;3(4):299-306. Review.

PMID:
16738193
29.
30.

Idiopathic pulmonary fibrosis.

Harari S, Caminati A.

Allergy. 2005 Apr;60(4):421-35. Review. No abstract available.

PMID:
15727572
31.

Bronchoalveolar lavage in intensive care units.

Pesci A, Majori M, Caminati A.

Monaldi Arch Chest Dis. 2004 Jan-Mar;61(1):39-43. Review.

PMID:
15366335
32.

Seasonal variations of T-cell cytokine pattern in peripheral blood from atopic subjects.

Majori M, Rossi G, Caminati A, Bosoni A, Corradi M, Pesci A.

J Asthma. 2001 Sep;38(6):469-76.

PMID:
11642413
33.

T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma.

Majori M, Caminati A, Corradi M, Brianti E, Scarpa S, Pesci A.

Clin Exp Allergy. 2000 Mar;30(3):341-7.

PMID:
10691891
34.

Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease.

Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):458-62.

PMID:
10069880

Supplemental Content

Loading ...
Support Center